Stay updated on Milademetan Safety in AML/MDS Clinical Trial
Sign up to get notified when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.

Latest updates to the Milademetan Safety in AML/MDS Clinical Trial page
- Check2 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous v3.6.2. This is an administrative revision label update without substantive content changes.SummaryDifference0.0%

- Check9 days agoChange DetectedThe page now shows Revision: v3.6.2 in place of the previous v3.6.0, signaling a backend/UI update rather than changes to the study details.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page adds user guidance sections and a reworded Intervention/Treatment heading, and displays the recruitment status 'No longer looking for participants' while updating the revision from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check30 days agoChange DetectedA new page revision tag v3.5.5 was added, replacing the previous v3.5.4, indicating a small backend update to the page without user-visible content changes.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page's revision line now displays Revision: v3.5.4, and the prior Revision: v3.5.3 entry was removed, reflecting a minor update to the page's revision history.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page’s revision identifier has been updated to v3.5.3, replacing the previous v3.5.2. This reflects a platform update without changes to the shown study details.SummaryDifference0.0%

Stay in the know with updates to Milademetan Safety in AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.